Product
ATH-063
1 clinical trial
4 indications
Indication
Inflammatory Bowel DiseaseIndication
Crohn's DiseaseIndication
ulcerative colitisIndication
Autoimmune DiseasesClinical trial
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Ascending Doses of ATH-063 in Healthy SubjectsStatus: Completed, Estimated PCD: 2024-02-08